Abiraterone With Different Steroid Regimens for Side Effect Related to Mineralcorticoid Excess Prevention in Prostate Cancer Prior to Chemotherapy
Clinical trial NCT01867710 · COMPLETED
Trial details
- NCT number
- NCT01867710
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-16
- Primary completion
- 2015-04-20
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.